DMMC COURSES & WORKSHOPS

CANCER BIOLOGY TO CANCER MEDICINE II
7 - 8 Jul 2005; 0900-1645 on Thu, 1000-1615 on Fri
Venue: Durkan Lecture Theatre, Institute of Molecular Medicine, TCD, St James's Hospital (location)
Application for this course is open to researchers throughout Ireland.
(please apply separately for each part of this course)

Course Coordinator: Prof Mark Lawler (Institute of Molecular Medicine, St James’s Hospital & TCD)

This DMMC course is designed to provide an overview of the main cellular and molecular processes involved in cancer development and progression, defining these processes in detail in a selected number of human malignancies. It will show how an increasing knowledge of cancer development and progression at the molecular level is providing a conduit for the application of molecular medicine in cancer diagnostics and cancer therapeutics. Comprising a series of lectures, round-table tutorials, specific disease focus lectures and case studies, the course aims to make participants aware not only of the underlying principles of cancer, but also of the practicalities in translating this knowledge for clinical benefit. Faculty for the course is drawn from both within and outside the DMMC, bringing together a cadre of experts to provide state-of-the-art knowledge and practical experiences in this important discipline.

The course is in two parts: Cancer Biology to Cancer Medicine I runs 26-27 May, while Cancer Biology to Cancer Medicine II (contents below) takes place 7-8 July. Taken together, both parts of the course are designed to provide a wide-ranging look at our current understanding of cancer and the practicalities of translational research in this area. We strongly recommend that those interested attend both parts of the course - please apply online separately for each part. It is advisable to apply early to ensure a place.

Day 1, Thu 7 Jul; 0900-1645

0900 Course Introduction
Prof Mark Lawler (IMM, TCD)
0915 Disease Focus III: Oesophageal and GI Cancers, Genetics and Environmental Influences
Prof John Reynolds (IMM, TCD)
1000 Round Table II: Genomic Instability and Cancer
Moderators: Dr Emer Bourke & Dr Ciaran Morrison (Department of Biochemistry and NCBES, National University of Ireland, Galway)

1130 Coffee/Tea

1200 BRCA1 Signalling and Cancer
Dr Paul Mullan (Queens University Belfast)
1245 Apoptotic Pathways in Cancer Development
Prof Mark Lawler (IMM, TCD)

1330 Lunch

1430 Disease Focus IV: Breast Cancer, Underlying Molecular Principles Dr William Gallagher (Conway Institute, UCD)
1515 Round Table III: Biomarkers
Moderators:
Prof Mark Lawler (IMM, TCD)
Prof Joe Duffy (St Vincent's University Hospital & UCD)
Dr Orla Sheils (IMM, TCD)

Day 2, Fri 8 Jul; 1000-1615

1000 Cancer Drug Development
Dr David Lloyd (Dept of Biochemistry, TCD)
1045 Signal Transduction Pathways as Targets for Cancer Therapeutics Dr Aideen Long (Dept of Biochemistry, RCSI)  Suggested reading

1130 Coffee/Tea

1200 Round Table IV: 'Omics in Cancer Medicine
Moderators:
Dr Orla Sheils (IMM, TCD)
Prof Stephen Pennington (Conway Institute, UCD)

1330 Lunch

1430 Case Studies II: Molecular Medicine in Action
Imatinib in Chronic Myeloid Leukemia
Dr Eibhlin Conneally (St James’s Hospital and TCD)
2nd topic and speaker to be confirmed
Breast Cancer Dr Andrew Green (National Centre for Medical Genetics, Crumlin)

1515 Molecular Medicine in Cancer: Can We Believe the Hype
Prof Mark Lawler (IMM, TCD)

1615 Round Up and End of the Course